{"transactions":[{"id":4639266,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-10-13T20:05:06.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":3846,"price":5.53,"value":21268.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 9, 2026 through October 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026."}],"balance_after":246855,"source":{"system":"sec-edgar","filing":"0001468308-26-000034","document":"form4-10132026_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000034/form4-10132026_041001.xml","form_type":"4"}},{"id":4634827,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-10-02T00:05:05.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":243009,"source":{"system":"sec-edgar","filing":"0001468308-26-000032","document":"form4-10012026_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000032/form4-10012026_041001.xml","form_type":"4"}},{"id":671955,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-09-01T00:09:14.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":241306,"source":{"system":"sec-edgar","filing":"0001468308-26-000030","document":"form4-09012026_120910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000030/form4-09012026_120910.xml","form_type":"4"}},{"id":672926,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-08-28T21:42:18.000Z","date":"2026-08-28","kind":"exercise","planned":true,"acquired":false,"shares":21928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option contract with exercise price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":779330,"derivative":{"exercise_price":5.1,"exercise_date":"2017-06-27","expiration_date":"2027-06-27","underlying":"Common Shares","underlying_shares":21928},"source":{"system":"sec-edgar","filing":"0001468308-26-000028","document":"form4-08282026_090813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000028/form4-08282026_090813.xml","form_type":"4"}},{"id":672925,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-08-28T21:42:18.000Z","date":"2026-08-28","kind":"exercise","planned":true,"acquired":true,"shares":21928,"price":5.1,"value":111832.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option contract with exercise price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":239603,"source":{"system":"sec-edgar","filing":"0001468308-26-000028","document":"form4-08282026_090813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000028/form4-08282026_090813.xml","form_type":"4"}},{"id":672924,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-08-28T21:42:18.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":11.78,"value":883500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2026, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). A portion of the sales proceeds from this transaction will be used by the reporting person to pay tax obligations of the reporting person."}],"balance_after":217675,"source":{"system":"sec-edgar","filing":"0001468308-26-000028","document":"form4-08282026_090813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000028/form4-08282026_090813.xml","form_type":"4"}},{"id":698806,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-08-03T20:05:09.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":292675,"source":{"system":"sec-edgar","filing":"0001468308-26-000026","document":"form4-08032026_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000026/form4-08032026_040801.xml","form_type":"4"}},{"id":721103,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-07-01T20:35:15.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":290972,"source":{"system":"sec-edgar","filing":"0001468308-26-000024","document":"form4-07012026_080710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000024/form4-07012026_080710.xml","form_type":"4"}},{"id":756958,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-06-01T20:05:06.000Z","date":"2026-05-31","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":289269,"source":{"system":"sec-edgar","filing":"0001468308-26-000022","document":"form4-06012026_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000022/form4-06012026_040601.xml","form_type":"4"}},{"id":795574,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-05-01T20:05:15.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":287566,"source":{"system":"sec-edgar","filing":"0001468308-26-000020","document":"form4-05012026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000020/form4-05012026_040501.xml","form_type":"4"}},{"id":819420,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":5.77,"value":692400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to this option may be exercised as of March 31, 2027 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":921045,"derivative":{"exercise_price":5.77,"exercise_date":"2027-03-31","expiration_date":"2036-03-31","underlying":"Options","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001468308-26-000018","document":"form4-04022026_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000018/form4-04022026_040401.xml","form_type":"4"}},{"id":819419,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":12270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":285863,"source":{"system":"sec-edgar","filing":"0001468308-26-000018","document":"form4-04022026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000018/form4-04022026_040401.xml","form_type":"4"}},{"id":819418,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":2213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":273593,"source":{"system":"sec-edgar","filing":"0001468308-26-000018","document":"form4-04022026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000018/form4-04022026_040401.xml","form_type":"4"}},{"id":819417,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":14724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on March 31, 2026."}],"balance_after":271380,"source":{"system":"sec-edgar","filing":"0001468308-26-000018","document":"form4-04022026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000018/form4-04022026_040401.xml","form_type":"4"}},{"id":827306,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-03-26T20:30:18.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":13072,"price":5.1,"value":66667.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":801045,"derivative":{"exercise_price":5.1,"exercise_date":"2017-06-27","expiration_date":"2027-06-27","underlying":"Options","underlying_shares":13072},"source":{"system":"sec-edgar","filing":"0001468308-26-000016","document":"form4-03262026_080309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000016/form4-03262026_080309.xml","form_type":"4"}},{"id":827305,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-03-26T20:30:18.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":13072,"price":5.1,"value":66667.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":256656,"source":{"system":"sec-edgar","filing":"0001468308-26-000016","document":"form4-03262026_080309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000016/form4-03262026_080309.xml","form_type":"4"}},{"id":866696,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-03-03T21:05:11.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":243584,"source":{"system":"sec-edgar","filing":"0001468308-26-000014","document":"form4-03032026_040303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000014/form4-03032026_040303.xml","form_type":"4"}},{"id":893271,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-02-19T23:43:44.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":2450,"price":4.08,"value":9996.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $4.08 and an expiration date of December 20, 2031."}],"balance_after":814117,"derivative":{"exercise_price":4.08,"exercise_date":"2021-12-20","expiration_date":"2031-12-20","underlying":"Options","underlying_shares":2450},"source":{"system":"sec-edgar","filing":"0001468308-26-000012","document":"form4-02192026_110240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000012/form4-02192026_110240.xml","form_type":"4"}},{"id":893270,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-02-19T23:43:44.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":27285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents settlement of PSUs that vested on February 18, 2026."}],"balance_after":242393,"source":{"system":"sec-edgar","filing":"0001468308-26-000012","document":"form4-02192026_110240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000012/form4-02192026_110240.xml","form_type":"4"}},{"id":893269,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-02-19T23:43:44.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":2450,"price":4.08,"value":9996.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $4.08 and an expiration date of December 20, 2031."}],"balance_after":215108,"source":{"system":"sec-edgar","filing":"0001468308-26-000012","document":"form4-02192026_110240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000012/form4-02192026_110240.xml","form_type":"4"}},{"id":924853,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-02-02T21:05:19.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":1558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":212658,"source":{"system":"sec-edgar","filing":"0001468308-26-000010","document":"form4-02022026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000010/form4-02022026_040201.xml","form_type":"4"}},{"id":932222,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-01-23T21:56:02.000Z","date":"2026-01-23","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":2.45,"value":24500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026."}],"balance_after":816567,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"Options","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001468308-26-000008","document":"form4-01232026_090158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000008/form4-01232026_090158.xml","form_type":"4"}},{"id":932221,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-01-23T21:56:02.000Z","date":"2026-01-23","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":2.45,"value":24500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026."}],"balance_after":211100,"source":{"system":"sec-edgar","filing":"0001468308-26-000008","document":"form4-01232026_090158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000008/form4-01232026_090158.xml","form_type":"4"}},{"id":938420,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-01-15T21:05:04.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":2.45,"value":24500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026."}],"balance_after":826567,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"Options","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001468308-26-000006","document":"form4-01152026_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000006/form4-01152026_040101.xml","form_type":"4"}},{"id":938419,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-01-15T21:05:04.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":2.45,"value":24500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026."}],"balance_after":201100,"source":{"system":"sec-edgar","filing":"0001468308-26-000006","document":"form4-01152026_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000006/form4-01152026_040101.xml","form_type":"4"}},{"id":944374,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-01-07T21:28:24.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":false,"shares":14184,"price":2.45,"value":34750.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026."}],"balance_after":836567,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"Options","underlying_shares":14184},"source":{"system":"sec-edgar","filing":"0001468308-26-000004","document":"form4-01072026_090120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000004/form4-01072026_090120.xml","form_type":"4"}},{"id":944373,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-01-07T21:28:24.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":true,"shares":14184,"price":2.45,"value":34750.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026."}],"balance_after":191100,"source":{"system":"sec-edgar","filing":"0001468308-26-000004","document":"form4-01072026_090120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000004/form4-01072026_090120.xml","form_type":"4"}},{"id":951137,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-01-05T21:05:31.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":1382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":176916,"source":{"system":"sec-edgar","filing":"0001468308-26-000002","document":"form4-01052026_040102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000002/form4-01052026_040102.xml","form_type":"4"}},{"id":983485,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-12-02T23:00:09.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":2430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":175534,"source":{"system":"sec-edgar","filing":"0001468308-25-000008","document":"form4-12022025_061205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830825000008/form4-12022025_061205.xml","form_type":"4"}},{"id":1009540,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-11-03T22:32:51.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":2430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":173104,"source":{"system":"sec-edgar","filing":"0001468308-25-000007","document":"form4-11032025_101147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830825000007/form4-11032025_101147.xml","form_type":"4"}},{"id":1029236,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-10-01T20:10:17.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":2430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":170674,"source":{"system":"sec-edgar","filing":"0001468308-25-000005","document":"form4-10012025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830825000005/form4-10012025_041001.xml","form_type":"4"}},{"id":1051396,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-09-02T20:10:08.000Z","date":"2025-08-31","kind":"grant","planned":false,"acquired":true,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":168244,"source":{"system":"sec-edgar","filing":"0001415889-25-023396","document":"form4-09022025_040903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925023396/form4-09022025_040903.xml","form_type":"4"}},{"id":1077503,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-08-01T20:20:04.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":165813,"source":{"system":"sec-edgar","filing":"0001415889-25-020849","document":"form4-08012025_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925020849/form4-08012025_040801.xml","form_type":"4"}},{"id":1097788,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-07-01T22:56:30.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":163382,"source":{"system":"sec-edgar","filing":"0001415889-25-018798","document":"form4-07012025_100726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925018798/form4-07012025_100726.xml","form_type":"4"}},{"id":1127564,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-06-02T21:01:49.000Z","date":"2025-05-31","kind":"grant","planned":false,"acquired":true,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":160951,"source":{"system":"sec-edgar","filing":"0001415889-25-015213","document":"form4-06022025_090644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925015213/form4-06022025_090644.xml","form_type":"4"}},{"id":1135206,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2025-05-23T20:20:06.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":8220,"price":5.1,"value":41922.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":850751,"derivative":{"exercise_price":5.1,"exercise_date":"2017-06-27","expiration_date":"2027-06-27","underlying":"Options","underlying_shares":8220},"source":{"system":"sec-edgar","filing":"0001415889-25-014467","document":"form4-05232025_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925014467/form4-05232025_040501.xml","form_type":"4"}},{"id":1135205,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-05-23T20:20:06.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":true,"shares":8220,"price":5.1,"value":41922.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":158520,"source":{"system":"sec-edgar","filing":"0001415889-25-014467","document":"form4-05232025_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925014467/form4-05232025_040501.xml","form_type":"4"}},{"id":1142586,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-05-19T20:30:32.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5-16-2024."}],"balance_after":150300,"source":{"system":"sec-edgar","filing":"0001415889-25-013641","document":"form4-05192025_040513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925013641/form4-05192025_040513.xml","form_type":"4"}},{"id":1162393,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-05-01T22:03:46.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":133633,"source":{"system":"sec-edgar","filing":"0001415889-25-011688","document":"form4-05012025_100543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925011688/form4-05012025_100543.xml","form_type":"4"}},{"id":1179443,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2025-04-03T23:12:53.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 28, 2025, Robert Andrade was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 28, 2026 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":877722,"derivative":{"exercise_price":6.5,"exercise_date":"2026-03-28","expiration_date":"2035-03-28","underlying":"Options","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-010063","document":"form4-04032025_110450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925010063/form4-04032025_110450.xml","form_type":"4"}},{"id":1179442,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-04-03T23:12:53.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 28, 2025, Robert Andrade was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the \"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction."}],"balance_after":827722,"derivative":{"exercise_price":0,"exercise_date":"2026-03-28","expiration_date":"2035-03-28","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-25-010063","document":"form4-04032025_110450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925010063/form4-04032025_110450.xml","form_type":"4"}},{"id":1186364,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-04-01T21:17:44.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":132591,"source":{"system":"sec-edgar","filing":"0001415889-25-009397","document":"form4-04012025_090441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925009397/form4-04012025_090441.xml","form_type":"4"}},{"id":1238340,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-02-28T23:53:21.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":131549,"source":{"system":"sec-edgar","filing":"0001415889-25-006066","document":"form4-02282025_110218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925006066/form4-02282025_110218.xml","form_type":"4"}},{"id":1287290,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-02-03T22:48:29.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":130507,"source":{"system":"sec-edgar","filing":"0001415889-25-002785","document":"form4-02032025_100225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925002785/form4-02032025_100225.xml","form_type":"4"}},{"id":1314504,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2025-01-03T22:47:05.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":129465,"source":{"system":"sec-edgar","filing":"0001415889-25-000606","document":"form4-01032025_100102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588925000606/form4-01032025_100102.xml","form_type":"4"}},{"id":1347117,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-12-03T00:09:05.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":128423,"source":{"system":"sec-edgar","filing":"0001415889-24-028020","document":"form4-12032024_121202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924028020/form4-12032024_121202.xml","form_type":"4"}},{"id":1361699,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2024-11-18T22:02:51.000Z","date":"2024-11-18","kind":"exercise","planned":false,"acquired":false,"shares":15816,"price":2.45,"value":38749.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026"}],"balance_after":689184,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"Options","underlying_shares":15816},"source":{"system":"sec-edgar","filing":"0001415889-24-027107","document":"form4-11182024_101148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924027107/form4-11182024_101148.xml","form_type":"4"}},{"id":1361698,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-11-18T22:02:51.000Z","date":"2024-11-18","kind":"exercise","planned":false,"acquired":true,"shares":15816,"price":2.45,"value":38749.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026"}],"balance_after":127381,"source":{"system":"sec-edgar","filing":"0001415889-24-027107","document":"form4-11182024_101148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924027107/form4-11182024_101148.xml","form_type":"4"}},{"id":1377092,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-11-04T22:30:05.000Z","date":"2024-10-31","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":111565,"source":{"system":"sec-edgar","filing":"0001415889-24-026038","document":"form4-11042024_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924026038/form4-11042024_051101.xml","form_type":"4"}},{"id":1396682,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-10-01T21:13:07.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":110523,"source":{"system":"sec-edgar","filing":"0001415889-24-024214","document":"form4-10012024_091004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924024214/form4-10012024_091004.xml","form_type":"4"}},{"id":1415571,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-09-04T22:33:18.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":109481,"source":{"system":"sec-edgar","filing":"0001415889-24-022812","document":"form4-09042024_050901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924022812/form4-09042024_050901.xml","form_type":"4"}},{"id":1444232,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-08-01T20:30:08.000Z","date":"2024-07-31","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":108439,"source":{"system":"sec-edgar","filing":"0001415889-24-020516","document":"form4-08012024_040803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924020516/form4-08012024_040803.xml","form_type":"4"}},{"id":1462895,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-07-02T21:42:34.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":107397,"source":{"system":"sec-edgar","filing":"0001415889-24-018984","document":"form4-07022024_090731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924018984/form4-07022024_090731.xml","form_type":"4"}},{"id":1495034,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-06-03T22:21:06.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":106355,"source":{"system":"sec-edgar","filing":"0001415889-24-015201","document":"form4-06032024_100602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924015201/form4-06032024_100602.xml","form_type":"4"}},{"id":1507089,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Share Unit (right to receive value of a share)","published_at":"2024-05-21T21:05:13.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On May 16, 2024, Robert Andrade was awarded restricted share units to acquire 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this award may be released from restriction as of May 16, 2025 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this award shall be released from restriction as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027, 100% of the total number of shares subject to this award shall be releaseed."}],"balance_after":778958,"derivative":{"exercise_price":0,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-013981","document":"form4-05212024_050503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924013981/form4-05212024_050503.xml","form_type":"4"}},{"id":1507088,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-21T21:05:13.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On May 16, 2024, Robert Andrade was granted incentive stock options to purchase 100,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to this option may be exercised as of May 16, 2025 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":728958,"derivative":{"exercise_price":7.12,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-24-013981","document":"form4-05212024_050503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924013981/form4-05212024_050503.xml","form_type":"4"}},{"id":1530492,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-05-02T21:03:14.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3-31-2023."}],"balance_after":105313,"source":{"system":"sec-edgar","filing":"0001415889-24-012018","document":"form4-05022024_090505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924012018/form4-05022024_090505.xml","form_type":"4"}},{"id":1549392,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-04-03T21:00:11.000Z","date":"2024-04-01","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents release of restriction from shares awarded 3-31-2023."}],"balance_after":104271,"source":{"system":"sec-edgar","filing":"0001415889-24-010059","document":"form4-04032024_050402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924010059/form4-04032024_050402.xml","form_type":"4"}},{"id":1559456,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-03-27T20:22:20.000Z","date":"2024-03-26","kind":"sale","planned":false,"acquired":false,"shares":13975,"price":10.9013,"value":152345.6675,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 plan adopted August 16, 2023."}],"balance_after":91771,"source":{"system":"sec-edgar","filing":"0001415889-24-009204","document":"form4-03272024_080308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924009204/form4-03272024_080308.xml","form_type":"4"}},{"id":1561815,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-03-25T23:31:07.000Z","date":"2024-03-25","kind":"sale","planned":true,"acquired":false,"shares":13975,"price":10.9975,"value":153690.0625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 plan adopted on August 16, 2023."}],"balance_after":105746,"source":{"system":"sec-edgar","filing":"0001415889-24-009068","document":"form4-03252024_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924009068/form4-03252024_110359.xml","form_type":"4"}},{"id":1685428,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-01-05T22:24:33.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":10.41,"value":156150.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold pursuant to a 10b5-1 plan adopted on June 14, 2023."}],"balance_after":119721,"source":{"system":"sec-edgar","filing":"0001415889-24-000781","document":"form4-01052024_100121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924000781/form4-01052024_100121.xml","form_type":"4"}},{"id":1685427,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2024-01-05T22:24:33.000Z","date":"2024-01-04","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":10.64,"value":159600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 plan adopted on June 14, 2023."}],"balance_after":134721,"source":{"system":"sec-edgar","filing":"0001415889-24-000781","document":"form4-01052024_100121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588924000781/form4-01052024_100121.xml","form_type":"4"}},{"id":1841050,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Shares","published_at":"2023-06-30T20:21:11.000Z","date":"2023-06-30","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":2.45,"value":61250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026."}],"balance_after":605000,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"Options","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-010459","document":"form4-06302023_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588923010459/form4-06302023_080609.xml","form_type":"4"}},{"id":1841049,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2023-06-30T20:21:11.000Z","date":"2023-06-30","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":2.45,"value":61250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares aquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026."}],"balance_after":149721,"source":{"system":"sec-edgar","filing":"0001415889-23-010459","document":"form4-06302023_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588923010459/form4-06302023_080609.xml","form_type":"4"}},{"id":1841048,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2023-06-30T20:21:11.000Z","date":"2023-06-30","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":8.82,"value":66150.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares sold pursuant to a 10b5-1 plan on June 30, 2023."}],"balance_after":124721,"source":{"system":"sec-edgar","filing":"0001415889-23-010459","document":"form4-06302023_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588923010459/form4-06302023_080609.xml","form_type":"4"}},{"id":1841047,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2023-06-30T20:21:11.000Z","date":"2023-06-29","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":8.97,"value":67275.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold pursuant to a 10b5-1 plan on June 29, 2023."}],"balance_after":132221,"source":{"system":"sec-edgar","filing":"0001415889-23-010459","document":"form4-06302023_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588923010459/form4-06302023_080609.xml","form_type":"4"}},{"id":1841046,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2023-06-30T20:21:11.000Z","date":"2023-06-28","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":8.99,"value":89900.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 plan on June 28, 2023."}],"balance_after":139721,"source":{"system":"sec-edgar","filing":"0001415889-23-010459","document":"form4-06302023_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588923010459/form4-06302023_080609.xml","form_type":"4"}},{"id":1932283,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Share Unit (right to receive value of a share)","published_at":"2023-04-03T20:25:34.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"1. On March 31, 2023, Robert Andrade was awarded restricted share units  to receive 37,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares subject to this award shall be released from restriction as of March 31, 2024 (the \"Vesting Commencement Date\"). 1/24 of the award  shall be released from restriction as of the last day of each month following the Vesting Commencement Date. As of March 31, 2026 and thereafter, 100% of the total number of shares subject to this award shall be released."}],"balance_after":667500,"derivative":{"exercise_price":0,"expiration_date":"2031-12-21","underlying":"Common Shares","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001415889-23-005781","document":"form4-04032023_080421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588923005781/form4-04032023_080421.xml","form_type":"4"}},{"id":1932282,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-03T20:25:34.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 31, 2023, Robert Andrade was granted incentive stock options to purchase 75,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2. 1/3 of the shares subject to this option shall vest immediately and may be exercised as of March 31, 2024 (the \"Vesting Commencement Date\"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2026 and thereafter, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":630000,"derivative":{"exercise_price":8.32,"expiration_date":"2033-03-31","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-23-005781","document":"form4-04032023_080421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588923005781/form4-04032023_080421.xml","form_type":"4"}},{"id":2074174,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2022-12-30T21:42:58.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":5500,"price":9.6122,"value":52867.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares sold pursuant to a 10b5-1 plan on December 30, 2022."}],"balance_after":149721,"source":{"system":"sec-edgar","filing":"0001415889-22-013102","document":"form4-12302022_091249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588922013102/form4-12302022_091249.xml","form_type":"4"}},{"id":2074173,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2022-12-30T21:42:58.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":5500,"price":9.5748,"value":52661.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold pursuant to a 10b5-1 plan on December 29, 2022."}],"balance_after":155221,"source":{"system":"sec-edgar","filing":"0001415889-22-013102","document":"form4-12302022_091249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588922013102/form4-12302022_091249.xml","form_type":"4"}},{"id":2074172,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2022-12-30T21:42:58.000Z","date":"2022-12-28","kind":"sale","acquired":false,"shares":11000,"price":9.6145,"value":105759.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 plan on December 28, 2022."}],"balance_after":160721,"source":{"system":"sec-edgar","filing":"0001415889-22-013102","document":"form4-12302022_091249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588922013102/form4-12302022_091249.xml","form_type":"4"}},{"id":2152655,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2022-09-22T15:02:51.000Z","date":"2022-09-21","kind":"disposition_to_issuer","acquired":false,"shares":19052,"price":8.54,"value":162704.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On September 21, 2022, 19,052 shares were netted back to the company to pay the taxes on the common shares released from restriction."}],"balance_after":171721,"source":{"system":"sec-edgar","filing":"0001415889-22-009828","document":"form4-09222022_080943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588922009828/form4-09222022_080943.xml","form_type":"4"}},{"id":2152654,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2022-09-22T15:02:51.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On September 21, 2022, 37,500 restricted share units were released from their restriction."}],"balance_after":190773,"source":{"system":"sec-edgar","filing":"0001415889-22-009828","document":"form4-09222022_080943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000141588922009828/form4-09222022_080943.xml","form_type":"4"}},{"id":2463769,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Unit (right to receive value of a share)","published_at":"2021-12-20T22:48:22.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On December 20, 2021, Robert Andrade was granted restricted share units to receive 37,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Item vests 100% upon FDA approval of PEDMARKTM."}],"balance_after":37500,"derivative":{"exercise_price":0,"expiration_date":"2031-12-20","underlying":"Common Shares","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001104659-21-151822","document":"tm2135965-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465921151822/tm2135965-2_4seq1.xml","form_type":"4"}},{"id":2463768,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-20T22:48:22.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On December 20, 2021, Robert Andrade was granted an incentive stock option to purchase 75,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Item vests 100% upon FDA approval of PEDMARKTM."}],"balance_after":75000,"derivative":{"exercise_price":4.08,"expiration_date":"2031-12-20","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-21-151822","document":"tm2135965-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465921151822/tm2135965-2_4seq1.xml","form_type":"4"}},{"id":2683155,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-03T15:58:03.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 2, 2021, Robert Andrade was granted an incentive stock option to purchase 100,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares subject to this option shall vest immediately and may be exercised as of June 2, 2022 (the \"Vesting Commencement Date\"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of May 31, 2024 and thereafter, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":100000,"derivative":{"exercise_price":7.53,"expiration_date":"2031-06-02","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-076222","document":"tm2118436-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465921076222/tm2118436-2_4seq1.xml","form_type":"4"}},{"id":3055865,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2020-08-17T20:06:45.000Z","date":"2020-08-17","kind":"tax_withholding","acquired":false,"shares":12874,"price":5.71,"value":73510.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 323,861 shares from an August 18, 2010 grant of 323,961 shares. The price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $5.63 to $5.80 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":153273,"source":{"system":"sec-edgar","filing":"0001104659-20-096098","document":"tm2028839d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465920096098/tm2028839d2_4.xml","form_type":"4"}},{"id":3055864,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2020-08-17T20:06:45.000Z","date":"2020-08-14","kind":"tax_withholding","acquired":false,"shares":38900,"price":5.68,"value":220952.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 323,861 shares from an August 18, 2010 grant of 323,961 shares. The price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $5.39 to $5.77 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":166147,"source":{"system":"sec-edgar","filing":"0001104659-20-096098","document":"tm2028839d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465920096098/tm2028839d2_4.xml","form_type":"4"}},{"id":3055863,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2020-08-17T20:06:45.000Z","date":"2020-08-13","kind":"tax_withholding","acquired":false,"shares":38828,"price":5.77,"value":224037.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 323,861 shares from an August 18, 2010 grant of 323,961 shares. The price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $5.62 to $5.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":205047,"source":{"system":"sec-edgar","filing":"0001104659-20-096098","document":"tm2028839d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465920096098/tm2028839d2_4.xml","form_type":"4"}},{"id":3055862,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2020-08-17T20:06:45.000Z","date":"2020-08-13","kind":"tax_withholding","acquired":false,"shares":97136,"price":6.17,"value":599329.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares sold per a net exercise of shares to cover the proceeds necessary for the exercise of 323,861 shares at a USD$1.85 exercise price from the August 18, 2010 grant of 323,961 shares with expiration of August 18, 2020."}],"balance_after":243875,"source":{"system":"sec-edgar","filing":"0001104659-20-096098","document":"tm2028839d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465920096098/tm2028839d2_4.xml","form_type":"4"}},{"id":3055861,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2020-08-17T20:06:45.000Z","date":"2020-08-13","kind":"exercise","acquired":true,"shares":323961,"price":1.85,"value":599327.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options granted on August 18, 2010 with a CAD$ strike price of $2.43 CAD converted at 0.76 CAD/USD exchange ratio with an expiration of August 18, 2020."}],"balance_after":341011,"source":{"system":"sec-edgar","filing":"0001104659-20-096098","document":"tm2028839d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465920096098/tm2028839d2_4.xml","form_type":"4"}},{"id":3147196,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-15T17:58:20.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On May 15, 2020, Robert Andrade was granted an incentive stock option to purchase 125,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares subject to this option shall vest immediately and may be exercised as of May 15, 2021 (the \"Vesting Commencement Date\"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of May 15, 2023 and thereafter, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":125000,"derivative":{"exercise_price":6.93,"expiration_date":"2030-05-15","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-20-062414","document":"tm2019938d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000110465920062414/tm2019938d3_4.xml","form_type":"4"}},{"id":3560305,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-08T15:28:57.000Z","date":"2019-04-04","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On April 4, 2019, Robert Andrade was granted an incentive stock option to purchase 80,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares subject to this option shall vest immediately and may be exercised as of April 4, 2020 (the \"Vesting Commencement Date\"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of April 4, 2022 and thereafter, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":80000,"derivative":{"exercise_price":4.83,"expiration_date":"2026-04-04","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001144204-19-018578","document":"tv518388_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000114420419018578/tv518388_4.xml","form_type":"4"}},{"id":3840041,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-17T20:33:58.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":17050,"price":1.44,"value":24552.0,"ownership":{"direct":true},"balance_after":17050,"source":{"system":"sec-edgar","filing":"0001144204-18-045375","document":"tv501320_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000114420418045375/tv501320_form4.xml","form_type":"4"}},{"id":4070370,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-09T02:02:50.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On February 6,, 2018, Robert Andrade was granted an incentive stock option to purchase 500,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares subject to this option shall vest immediately and may be exercised as of February 6, 2019 (the \"Vesting Commencement Date\"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 6, 2021 and thereafter, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":50000,"derivative":{"exercise_price":8.38,"expiration_date":"2025-02-06","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-18-006729","document":"tv485382_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000114420418006729/tv485382_4.xml","form_type":"4"}}]}